Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase beta (Pol β) and the replication-associated DNA polymerases (alpha, delta, and epsilon) are essential enzymes responsible for synthesizing DNA strands and maintaining genomic integrity. Pol β is a specialized enzyme primarily involved in the base excision repair (BER) pathway, where it fills short gaps in DNA following the removal of damaged bases (Beard & Wilson, 2006). In contrast, DNA polymerases alpha, delta, and epsilon are the primary engines of nuclear DNA replication, coordinating the synthesis of leading and lagging strands during the S-phase of the cell cycle (Burgers & Kunkel, 2017). These enzymes are critical therapeutic targets in oncology, as their inhibition can lead to DNA damage accumulation, cell cycle arrest, and apoptosis in rapidly dividing cancer cells (UniProt Consortium, 2024). Many chemotherapeutic agents, such as nucleoside analogs like Cytarabine and Gemcitabine, function by competing with natural nucleotides for incorporation by these polymerases or by directly inhibiting their catalytic activity (National Cancer Institute, 2023). Because this target entry aggregates multiple distinct enzymes with different primary biological roles, it is classified as containing too much information for a single canonical target profile.
Inhibition of DNA synthesis through competitive binding with deoxyribonucleotide triphosphates (dNTPs) or induction of DNA chain termination upon incorporation into the nascent DNA strand (National Cancer Institute, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase beta and DNA replication polymerases (Pol β, Pol α, Pol δ, Pol ε).